Influence of long-term use of inhaled corticosteroid on Toll like receptor 2 expression in induced sputum in severe chronic obstructive pulmonary disease patients

朱海星,施宇衡,汤葳,时国朝,万欢英

DOI: https://doi.org/10.3969/j.issn.1673-6087.2013.06.013

2013-01-01

Abstract:Objective To evaluate the influence of long-term use of inhaled corticosteroid on Toll like receptor 2(TLR2)expression on and in macrophages from induced sputum in severe chronic obstructive pulmonary disease(COPD) patients. Methods Severe smoking stable COPD male patients treated in COPD out patient department were divided into two groups: long-term inhaled corticosteroid(ICS) treatment group(ICS≥500 μg/d futicasone propionate, ≥1 year)(n=21) and ICS naive group(n=29). The TLR2 extracellular(surface) and intracellular expression in macrophages from induced sputum were detected by cytometry. The mRNA expressions of TLR2 and tumor necrosis factor(TNF) α in cells from induced sputum were assayed by real-time PCR. Results The TLR2 extracellular expression on macrophages from induced sputum in long-term ICS treatment group was lower than that in the ICS naive group(5.35±1.67 vs 12.81±4.89, P=0.019). The TLR2 intracellular expression in macrophages(13.69±1.17 vs 20.12±4.37), the TLR2 mRNA(3.64±1.61 vs 5.13 ±1.41) and TNF-α mRNA(6.92 ±2.23 vs 8.18 ±1.49) expressions also showed decreased trends in ICS long-term treatment group when compared with ICS naive group but had not reached significant level. There were positive correlations between TLR2 extracellular and TLR2 intracellular expressions(r=0.645, P=0.017), as well as between TNF-α mRNA and TLR2 extracellular expressions(r=0.716, P=0.012). Conclusions Long-term use of ICS may have negative influence on TLR2 expression in airway of COPD patients, which may increase the susceptibility to pulmonary infection in severe COPD patients.